Communiqués Krystal Biotech, Inc.

Actions

KRYS

US5011471027

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 11/06/2024			Varia. 5j.	Varia. 1 janv.
177,5 ^USD	+0,37 %		+10,17 %	+43,06 %

16:40	Transcript : Krystal Biotech, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM
10/06	KKR & Co, CrowdStrike et GoDaddy rejoindront l'indice S&P 500 le 24 juin	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference	05/06	AQ
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference	15/05	AQ
Krystal Biotech to Present at BofA Securities 2024 Health Care Conference	08/05	AQ
Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates	06/05	AQ
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting	02/05	AQ
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024	26/04	AQ
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung	22/04	AQ
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	05/04	AQ
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	04/04	AQ
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	29/02	AQ
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	28/02	AQ
Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	26/02	AQ
Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024	21/02	AQ
Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024	20/02	AQ
Cystic Fibrosis Pipeline Insights Report 2024 \| Krystal Biotech, Vertex Pharmaceuticals, Translate Bio, Novartis, and others.	19/02	AQ
Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung	13/02	AQ
Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis Bullosa	08/02	AQ
Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology Conference	01/02	AQ
Krystal Biotech Receives Permanent J-code (J3401) for VYJUVEK®	04/01	AQ
Krystal Biotech Receives Orphan Drug Designation from the Japanese MHLW for Beremagene Geperpavec-svdt	20/12	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Krystal Biotech, Inc.

Actions

KRYS

US5011471027

Communiqués

Filtres